SOLIGENIX, INC.
SOLIGENIX, INC. is a federal contractor, registered under UEI GVD4XBVYD9J5 and CAGE code 44FA7. It has been awarded $56,546,560 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology), Research and Development in Biotechnology, and Unknown NAICS. Top awarding agencies include Department Of Health And Human Services and Department Of Health And Human Services (hhs).
Contact Information
Registration and classification details
Registration
UEI Code
GVD4XBVYD9J5CAGE Code
44FA7Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
SOLIGENIX, INC. specializes in advanced biotechnological research and development, with a focus on therapeutic protein engineering, vaccine platform technologies, and immunomodulatory product development. The company leverages deep expertise in molecular biology, recombinant protein expression syste...
SOLIGENIX, INC. specializes in advanced biotechnological research and development, with a focus on therapeutic protein engineering, vaccine platform technologies, and immunomodulatory product development. The company leverages deep expertise in molecular biology, recombinant protein expression systems, and preclinical pharmacology to advance novel medical countermeasures for infectious diseases and oncology indications. Their technical capabilities include GMP-compatible manufacturing process development, analytical characterization of biologics, and regulatory pathway strategy for FDA submission. SOLIGENIX differentiates itself through proprietary delivery platforms and targeted immune activation approaches, emphasizing translational science from laboratory innovation to clinical readiness. Award history is not available to determine specific agency relationships or project types, so no definitive patterns of engagement with federal entities can be inferred from the provided data. The company operates primarily within the scientific research and development sector, aligned with NAICS 541714, which encompasses custom biotechnology services and applied life sciences R&D. In practice, this means SOLIGENIX delivers specialized contract research and development services to support government and private-sector initiatives in biodefense, pandemic preparedness, and targeted therapeutics. Their market positioning centers on high-complexity, low-volume biologics development requiring stringent quality control and regulatory compliance. SOLIGENIX, INC. is a small business structured as a 2L entity, headquartered in Princeton, New Jersey. The company holds no federal certifications such as 8(a), HUBZone, or WOSB. Its government market presence is defined by its technical specialization in biopharmaceutical innovation rather than broad-scale service delivery. The firm maintains a focused operational footprint centered on R&D laboratories and process development facilities in its Princeton location.
Key Performance Metrics
Awards Count
16
All time
Active
0
Currently performing
Completed
16
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with SOLIGENIX, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for SOLIGENIX, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
